Stock TXMD THERAPEUTICSMD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Market Closed - Nasdaq
Other stock markets
 21:30:00 02/05/2024 BST 		5-day change 1st Jan Change
1.895 USD +0.53% Intraday chart for TherapeuticsMD, Inc. +1.34% -15.78%
03-29 TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-06 Knight Therapeutics Announces Launch of Bijuva in Canada MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
TherapeuticsMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
TherapeuticsMD, Inc. Announces Evaluation of Strategic Alternatives
ETF: profiteren van de vergrijzing
TherapeuticsMD, Inc. Announces Executive Changes
TherapeuticsMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Pas de problème, la Fed est là
En Direct des Marchés : Stellantis, TotalEnergies, Bouygues, Edenred, Microsoft, Amgen, KBC, Sonova...
TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
TherapeuticsMD, Inc. Auditor Raises 'Going Concern' Doubt
TherapeuticsMd, Inc. Announces Chief Executive Officer Changes
TherapeuticsMd, Inc. Announces Executive Changes
Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday
TherapeuticsMD Completes Product License Deal to Mayne Pharma Group
Mayne Pharma Group Limited Completes TherapeuticsMD, Inc. Product Licensing Transaction
Mayne Pharma, Inc. completed the acquisition of Certain Assets of TherapeuticsMD, Inc.
TherapeuticsMD Agrees to Grant Product License to Mayne Pharma Group; Shares Surge Pre-Bell
Mayne Pharma Group Signs Exclusive License Deal for Women's Health Products, Prenatal Vitamins; Shares Slump 13%
TherapeuticsMD, Inc. Enter into Definitive Agreements to License its Products to an Affiliate of Mayne Pharma Group Limited for Commercialization in the United States
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TXMD Stock
  4. News TherapeuticsMD, Inc.
  5. Other languages